Innovation Theaters

September 23-25, 2021


LONSURF® (trifluridine and tipiracil) tablets: Oral chemotherapy for previously treated metastatic colorectal, gastric and gastroesophageal (GEJ) cancers
Ben George, MD
Thursday, September 23 at 12:05 PM Eastern

Presented by: 


Let’s Take a Closer Look – How overall survival results fit into a broader clinical story regarding two side of the colon in metastatic colorectal cancer
Dr. Richard Kim
Thursday, September 23 at 3:40 PM Eastern

Presented by:


PEMAZYRE™ (pemigatinib): The First FDA-Approved Treatment for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma (CCA) with an FGFR2 Fusion or Rearrangement
Sujith Kalmadi, MD
Friday, September 24 at 11:05 AM Eastern

Presented by:


Clinical Management of HCC with CABOMETYX
Farshid Dayyani, MD, PhD
Friday, September 24 at 3:10 PM Eastern

Presented by:


The Determined Patient: A Case-Based Presentation on CYRAMZA
Dr. Catenacci
Saturday, September 25 at 10:55 AM Eastern

Presented by:


This Innovation Theater non-CME presentation is taking place during Great Debates & Updates in Gastrointestinal Malignancies. The opinions and recommendations expressed do not necessarily reflect the views of the Great Debates & Updates in Gastrointestinal Malignancies, Imedex, HMP Global or NACCME. This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE. By participating in the Innovation Theater presentation, you opt-in to share/receive information with/from industry sponsors. If you wish to opt-out, email optouts@gioncologydebates.com